Management of Dyslipidemia in the Metabolic Syndrome-Reference-Cited by-同舟云学术

Management of Dyslipidemia in the Metabolic Syndrome

Published:2007 Issue:1 Volume:7 Page:39-58
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:American Journal of Cardiovascular Drugs

Author:

Ascaso Juan,Gonzalez Santos Pedro,Hernandez Mijares Antonio,Mangas Rojas Alipio,Masana Luis,Millan Jesus,Pallardo Luis Felipe,Pedro-Botet Juan,Perez Jimenez Francisco,Pint?? Xavier,Plaza Ignacio,Rubi??s Juan,Z????iga Manuel

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Reference86 articles.

1. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.

2. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis

3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

4. Lipoprotein lipase in diabetes

5. Relation of LDL Size to the Insulin Resistance Syndrome and Coronary Heart Disease in American Indians

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic syndrome burden, determinants and treatment status in an urban slum resettlement colony in Delhi, India;International Health;2024-03-22

2. Management of lipid abnormalities in metabolic syndrome;Metabolic Syndrome;2024

3. Association between metabolic syndrome and risk of incident dementia in UK Biobank;Alzheimer's & Dementia;2023-09-07

4. SmartLab 2.0 in cardiovascular prevention of atherogenic dyslipidemia;Clínica e Investigación en Arteriosclerosis (English Edition);2023-05

5. SmartLab 2.0 en prevención cardiovascular de dislipemia aterogénica;Clínica e Investigación en Arteriosclerosis;2022-11